WallStSmart

FatPipe, Inc. Common Stock (FATN)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Zepp Health Corp generates 1541% more annual revenue ($258.90M vs $15.78M). FATN leads profitability with a 4.1% profit margin vs -15.5%. FATN earns a higher WallStSmart Score of 47/100 (D+).

FATN

Hold

47

out of 100

Grade: D+

Growth: 8.0Profit: 5.0Value: 6.3Quality: 5.0

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

FATNUndervalued (+64.0%)

Margin of Safety

+64.0%

Fair Value

$5.25

Current Price

$3.04

$2.21 discount

UndervaluedFair: $5.25Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

FATN3 strengths · Avg: 8.7/10
EPS GrowthGrowth
327.7%10/10

Earnings expanding 327.7% YoY

Price/BookValuation
2.0x8/10

Reasonable price relative to book value

Revenue GrowthGrowth
29.8%8/10

Revenue surging 29.8% year-over-year

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

FATN4 concerns · Avg: 3.3/10
P/E RatioValuation
40.0x4/10

Premium valuation, high expectations priced in

Market CapQuality
$27.85M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
3.4%3/10

ROE of 3.4% — below average capital efficiency

Profit MarginProfitability
4.1%3/10

4.1% margin — thin

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : FATN

The strongest argument for FATN centers on EPS Growth, Price/Book, Revenue Growth. Revenue growth of 29.8% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : FATN

The primary concerns for FATN are P/E Ratio, Market Cap, Return on Equity. Thin 4.1% margins leave little buffer for downturns.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

FATN profiles as a growth stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor SOFTWARE - INFRASTRUCTURE industry trends, competitive dynamics, and regulatory changes.

Bottom Line

FATN scores higher overall (47/100 vs 41/100) and 29.8% revenue growth. ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

FatPipe, Inc. Common Stock

TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA

FatPipe, Inc. develops secure software-defined wide area network (SD-WAN), secure access service edge (SASE), and network monitoring service (NMS) software solutions for organizations in the United States and internationally. The company is headquartered in Salt Lake City, Utah.

Visit Website →

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?